Cargando…
Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
Multiple myeloma (MM) remains a largely incurable, genetically heterogeneous plasma-cell malignancy that contains – just like many other cancers – a small fraction of clonogenic stem cell-like cells that exhibit pronounced self-renewal and differentiation capacities, but also pronounced drug resista...
Autores principales: | Franqui-Machin, Reinaldo, Wendlandt, Erik B., Janz, Siegfried, Zhan, Fenghuang, Tricot, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747348/ https://www.ncbi.nlm.nih.gov/pubmed/26415231 |
Ejemplares similares
-
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
por: Yang, Ye, et al.
Publicado: (2014) -
Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma
por: Zhan, Xin, et al.
Publicado: (2017) -
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2018) -
Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019) -
Fact or fiction - identifying the elusive multiple myeloma stem cell
por: Kellner, Joshua, et al.
Publicado: (2013)